Q5E304
Gene name |
VF_2097 |
Protein name |
tRNA-modifying protein YgfZ |
Names |
|
Species |
Aliivibrio fischeri (strain ATCC 700601 / ES114) (Vibrio fischeri) |
KEGG Pathway |
vfi:VF_2097 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5E304
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5E304-F1 | Predicted | AlphaFoldDB |
No variants for Q5E304
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q5E304 | |||||
No associated diseases with Q5E304
1 regional properties for Q5E304
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| conserved_site | YgfZ/GcvT conserved site | 182 - 245 | IPR017703 |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| folic acid binding | Binding to folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| RNA modification | The covalent alteration of one or more nucleotides within an RNA molecule to produce an RNA molecule with a sequence that differs from that coded genetically. |
| tRNA processing | The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MMSTLFPALN | LNKDEPLPSF | TVSELNDWAL | ITMIGADKKS | YLQGQVTCDV | VSLAQDEITF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GGHCDAKGKL | WSIFQLFHHN | DGYALFQRKS | AIETELTEIK | KYAVFSKVDI | SISDEILLGF |
| 130 | 140 | 150 | 160 | 170 | 180 |
| TGDKALEWIN | QHTDSNANVR | VSKFGTFAKV | SDTQWLLVTT | DDKKEELLSL | LSEATLCDEA |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IWSLHHIKHA | LPQIDAPLCN | EHIPQALNLQ | AINGISFKKG | CYTGQETVAR | AKYRGINKRA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| MYLLSGLSEA | RPCAGDAIER | SVGENWRKGG | TIVSAYRFED | GHTLALAILP | NDLDEDTQFK |
| 310 | |||||
| LQESIWEKVE | LPYSLNDE |